Blood Biomarkers for Use in Alzheimer Disease - Moving from "if" to "how?"

Research output: Contribution to journalEditorialResearch

Original languageEnglish
JournalJAMA Neurology
DOIs
StatePublished - 1 Jan 2019

Fingerprint

Alzheimer Disease
Biomarkers

Cite this

@article{e9582a57a7dc4b9197ca83a95f0fcb41,
title = "Blood Biomarkers for Use in Alzheimer Disease - Moving from {"}if{"} to {"}how?{"}",
author = "Sidney O'Bryant",
year = "2019",
month = "1",
day = "1",
doi = "10.1001/jamaneurol.2019.0845",
language = "English",
journal = "JAMA Neurology",
issn = "2168-6149",
publisher = "American Medical Association",

}

Blood Biomarkers for Use in Alzheimer Disease - Moving from "if" to "how?". / O'Bryant, Sidney.

In: JAMA Neurology, 01.01.2019.

Research output: Contribution to journalEditorialResearch

TY - JOUR

T1 - Blood Biomarkers for Use in Alzheimer Disease - Moving from "if" to "how?"

AU - O'Bryant, Sidney

PY - 2019/1/1

Y1 - 2019/1/1

UR - http://www.scopus.com/inward/record.url?scp=85067870944&partnerID=8YFLogxK

U2 - 10.1001/jamaneurol.2019.0845

DO - 10.1001/jamaneurol.2019.0845

M3 - Editorial

JO - JAMA Neurology

JF - JAMA Neurology

SN - 2168-6149

ER -